Expert opinion on managing chronic HCV in patients with cardiovascular disease

Salvatore Petta, Antonio Craxi, Alessia Pepe, Mark Bondin, Cristina Vassalle, Patrice Cacoub

Risultato della ricerca: Articlepeer review

3 Citazioni (Scopus)

Abstract

Extrahepatic manifestations of chronic HCV infection include cardiovascular diseases and an increase in cardiovascular mortality. The pathogenic mechanisms by which HCV contributes to cardiovascular disease are not well defined, however, it is likely that systemic inflammation, and the promotion of other metabolic diseases are involved. In this Review, the evidence for HCV infection as a non-traditional risk factor for cardiovascular disease is evaluated. Furthermore, practical advice to evaluate cardiovascular disease risk and disease in chronic hepatitis C patients are included for help in daily clinical practice. Despite the advances in therapies for the treatment of HCV, there remains a need for increased awareness among specialists so that patients are more likely to obtain the treatment required to mitigate disease progression.
Lingua originaleEnglish
pagine (da-a)35-46
Numero di pagine12
RivistaAntiviral Therapy
Volume23
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Entra nei temi di ricerca di 'Expert opinion on managing chronic HCV in patients with cardiovascular disease'. Insieme formano una fingerprint unica.

Cita questo